Correlation Between Zane Interactive and Raphael Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Zane Interactive and Raphael Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zane Interactive and Raphael Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zane Interactive Publishing and Raphael Pharmaceutical, you can compare the effects of market volatilities on Zane Interactive and Raphael Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zane Interactive with a short position of Raphael Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zane Interactive and Raphael Pharmaceutical.

Diversification Opportunities for Zane Interactive and Raphael Pharmaceutical

0.0

Correlation Coefficient

Zane Interactive  Raphael Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Zane and Raphael is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zane Interactive Publishing and Raphael Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raphael Pharmaceutical and Zane Interactive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zane Interactive Publishing are associated (or correlated) with Raphael Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raphael Pharmaceutical has no effect on the direction of Zane Interactive i.e., Zane Interactive and Raphael Pharmaceutical go up and down completely randomly.

Pair Corralation between Zane Interactive and Raphael Pharmaceutical

Given the investment horizon of 90 days Zane Interactive Publishing is expected to under-perform the Raphael Pharmaceutical. But the pink sheet apears to be less risky and, when comparing its historical volatility, Zane Interactive Publishing is 2.34 times less risky than Raphael Pharmaceutical. The pink sheet trades about -0.04 of its potential returns per unit of risk. The Raphael Pharmaceutical is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  250.00  in Raphael Pharmaceutical on October 11, 2024 and sell it today you would lose (175.00) from holding Raphael Pharmaceutical or give up 70.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Zane Interactive Publishing  vs.  Raphael Pharmaceutical

Zane Interactive Pub

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zane Interactive Publishing has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Zane Interactive is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Raphael Pharmaceutical

Risk-Adjusted Performance

4 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Raphael Pharmaceutical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Raphael Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zane Interactive and Raphael Pharmaceutical

The main advantage of trading using opposite Zane Interactive and Raphael Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zane Interactive position performs unexpectedly, Raphael Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raphael Pharmaceutical will offset losses from the drop in Raphael Pharmaceutical's long position.

The idea behind Zane Interactive Publishing and Raphael Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.